How was that of benefit to Hopper and the insiders when the SP is now lower than what they paid? Are the insiders now loading up in the knowledge that the trial pinpointed indications in the area of solid tumours, perhaps? Another poster highlighted the updated trial information on the official site which had the addition of Gastric/Esophageal Cancer. Not a bad outcome based on three patients. A CR in AML out of how many patients in a trial at that juncture had 3 patients with either a blood cancer OR a solid tumour cancer. I believe what is contained in the clinical trial study is quite telling, don't you?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)